Home › Funds › Livforsakringsbolaget Skandia, Omsesidigt › COR

Livforsakringsbolaget Skandia, Omsesidigt position in COR

CENCORA INC · Health Care

Livforsakringsbolaget Skandia, Omsesidigt reported holding 62,075 shares of COR (CENCORA INC) in its Q2 2026 13F filing — a position valued at US$17.6M, representing 0.56% of its reported portfolio and ranking #46 among its reported holdings. Livforsakringsbolaget Skandia, Omsesidigt has disclosed COR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)62.08K sh
Reported value held$17.57M
Portfolio Weight0.56%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Livforsakringsbolaget Skandia, Omsesidigt's COR position evolved

Livforsakringsbolaget Skandia, Omsesidigt first disclosed a stake in COR in Q3 2023 at 9,694 shares (US$1.7M). The position peaked in Q1 2026 at 62,075 shares, worth US$19.5M. Across 12 filings, Livforsakringsbolaget Skandia, Omsesidigt increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 62,075 shares valued at US$17.6M. Notable position changes include a 62% increase in Q4 2023 (shares rose 18% over the following quarter), a 95% trim in Q2 2025 (shares rose 4% over the following quarter), a 2917% increase in Q3 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.69K $1.74M New
Q4 2023 15.68K $3.22M Add
Q1 2024 18.98K $4.61M Add
Q2 2024 20.48K $4.61M Add
Q3 2024 27.38K $6.16M Add
Q4 2024 28.57K $6.42M Add
Q1 2025 38.88K $10.81M Add
Q2 2025 1.88K $562.01K Reduce
Q3 2025 56.58K $17.68M Add
Q4 2025 56.58K $19.11M Hold
Q1 2026 62.08K $19.50M Add
Q2 2026 62.08K $17.57M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COR and 13F data

COR (CENCORA INC) is a Health Care company. 36 other funds we track also report a position in COR — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.38B), Carmignac Gestion (US$494.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COR

All COR fund holders →

FAQ

How long has Livforsakringsbolaget Skandia, Omsesidigt held COR?

Livforsakringsbolaget Skandia, Omsesidigt has disclosed COR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Livforsakringsbolaget Skandia, Omsesidigt's current position in COR?

As of Q2 2026, Livforsakringsbolaget Skandia, Omsesidigt holds 62.08K shares of COR (CENCORA INC), valued at $17.57M, representing 0.56% of its reported portfolio and ranking #46.

Has Livforsakringsbolaget Skandia, Omsesidigt been buying or selling COR?

In the latest 13F filing (Q2 2026), Livforsakringsbolaget Skandia, Omsesidigt held unchanged its position in COR. The position peaked in Q1 2026 at 62.08K shares.

Which other funds hold COR?

Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Carmignac Gestion, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.